Share:
GERMANTOWN, Tenn., May 3, 2021 /PRNewswire-PRWeb/ Born in London, Dr. Purvisha Patel was raised in Wales (United Kingdom) and Virginia. She completed her undergraduate and medical school studies at the University of Virginia. She completed her dermatology training at The University of Tennessee Health Science Center in Memphis. During residency, Dr. Patel discovered her passion for treating skin cancer and anti-aging and went on to complete a surgical fellowship under the tutelage of Dr. Michael McCall at the University of Louisville in Kentucky. Dr. Patel is certified by the American Board of Dermatology and is a member of the American Academy of Dermatology and the American Society for Dermatologic Surgery. She is a fellow of the American College of Mohs Micrographic Surgery and Cutaneous Oncology and serves as a clinical professor of the University of Tennessee Department of Dermatology. Dr. Patel s expertise in skin and skincare is also seen as she formulated and paten
Published: May 03, 2021
KIRKLAND, WA – May 3, 2021 Amcyte Pharma, a Seattle-based company dedicated to the commercialization of immunomodulators, announced the results of an independent clinical trial among ICU staff suggesting that its product, Nasitrol
TM nasal spray, represents a safe and effective treatment that could prevent transmission of COVID-19. Amcyte will market Nasitrol in the U.S. through a licensing agreement from Laboratorio Pablo Cassara, an Argentinean pharma company leader in innovation.
Nasitrol is a patented nasal spray based on iota carrageenan, a sulfate polysaccharide synthesized by red algae, with demonstrated antiviral activity and clinical efficacy as a nasal spray in the treatment of the common cold. A previous study at the University of Tennessee Health Science Center found that the iota carrageenan formulation inhibits infection by SARS-CoV-2, the virus that causes COVID-19, in cell culture in vitro.
The National Institute of Environmental Health Sciences has awarded Byron C. Jones, PhD, professor in the Department of Genetics, Geonomics, and Informatics at the University of Tennessee Health Science Center, $2.87 million for his continuing study of genetic alterations associated with Gulf War illness among former military personnel.
Targeted News Service targetednews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from targetednews.com Daily Mail and Mail on Sunday newspapers.